Skip to main content
. 2013 Oct 4;8(10):e75507. doi: 10.1371/journal.pone.0075507

Figure 8. Effect of SapC-DOPS nanovesicles on pancreatic tumor growth.

Figure 8

Subcutaneous tumors (MiaPaCa-2 cell line) treated with SapC-DOPS nanovesicles had significantly reduced tumor end-volume (A) and end-weight (B) compared to controls.